Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 791-801
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.791
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.791
Figure 1 Flow chart of participant selection.
NAFLD: Nonalcoholic fatty liver disease.
Figure 2 Relationship between total cholesterol to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease by smooth curve fitting.
Adjustment variables: Sex, age, body mass index, aminotransferase, aminotransferase, γ-glutamyl transpeptidase, platelets, hepatitis B surface antigen, creatinine, uric acid, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B, hepatitis B virus DNA (+), Hepatitis B e antigen (+), nucleoside analogs. TC/HDL-C: Total cholesterol to high-density lipoprotein cholesterol ratio; NAFLD: Nonalcoholic fatty liver disease.
- Citation: Zhou YG, Tian N, Xie WN. Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B. World J Hepatol 2022; 14(4): 791-801
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/791.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.791